Ex vivo biodistribution in C57BL/6 mouse spleen at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse liver at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse kidney at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse lung at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse bone at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse heart at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse brain at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse Gall bladder at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse blood at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse urine at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse White adipose tissue at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method
Ex vivo biodistribution in C57BL/6 mouse Brown adipose tissue at 16.50 to 17.59 MBq, iv preincubated in presence of PF-06795071 followed by compound addition for 30 mins by gamma counter method